Lithium for Bipolar Disorder: How It Works, What the Side Effects Are, and Why It's Still the Gold Standard

Glowing neon brain with lithium chemical symbol Li 6.941 in center — Illustration showing the connection between lithium and brain activity

Lithium Has Treated Bipolar Disorder for More Than 70 Years. Here Is the Science Behind Why It Works.

Lithium is one of the oldest psychiatric medications still in widespread use, and in an era of newer, heavily marketed mood stabilizers, it remains the treatment most psychiatrists reach for first when managing bipolar disorder. That longevity is not inertia. It reflects decades of evidence that no other mood stabilizer has fully matched its effectiveness for preventing both manic and depressive episodes over time.

For many people newly diagnosed with bipolar disorder, lithium raises questions: How does a simple mineral salt affect the brain? What are the real risks? And if it works so well, why do so many people stop taking it?

How Lithium Works in the Brain

Lithium is a naturally occurring element, not a compound synthesized in a laboratory, which makes its effectiveness in treating a complex psychiatric condition all the more striking. Researchers have studied its mechanism for decades without reaching a single complete explanation, which itself reflects the complexity of bipolar disorder.

What is well established is that lithium influences multiple systems in the brain simultaneously. It modulates the activity of neurotransmitters including serotonin, dopamine, and norepinephrine, all of which are involved in mood regulation. It also inhibits two enzymes, inositol monophosphatase and glycogen synthase kinase-3 (GSK-3), that play roles in how brain cells signal each other.

Beyond neurotransmitter effects, research has shown that lithium has neuroprotective properties. It appears to reduce neuroinflammation and may protect against the gray matter loss that has been observed in people with repeated manic episodes. A 2025 study examined lithium’s mechanism in greater detail, finding further evidence that its effects on calcium channel activity may explain its particular effectiveness in mania.

What the Evidence Shows

The clinical record for lithium is difficult to dispute. Multiple large-scale studies and decades of practice have found it reduces the frequency and severity of manic episodes and lowers suicide risk in people with bipolar disorder. A 2017 meta-analysis published in Lancet Psychiatry found lithium more effective than other mood stabilizers in preventing relapse across both poles of bipolar disorder.

Its antisuicidal effect is distinctive and not fully explained by mood stabilization alone. Lithium is the only mood stabilizer with consistent evidence for reducing suicide risk, a quality that influences treatment decisions for patients assessed as high risk.

The Side Effects: What Patients Actually Experience

Lithium’s side effect profile is real and worth understanding clearly. At therapeutic doses, common side effects include hand tremor, increased thirst, increased urination, mild cognitive slowing, and weight gain. Some people experience nausea, particularly when first starting the medication or after a dose increase.

The more serious concern is lithium toxicity. Because lithium has a narrow therapeutic window, the difference between an effective dose and a toxic dose is smaller than with most medications. Blood tests are required regularly to monitor serum lithium levels, kidney function, and thyroid function.

Signs of lithium toxicity include coarse tremor, confusion, slurred speech, and coordination problems. Toxicity risk increases with dehydration, illness that reduces fluid intake, and certain medications including some blood pressure drugs and anti-inflammatory pain relievers like ibuprofen. Patients on lithium are advised to stay well hydrated and to avoid nonsteroidal anti-inflammatory drugs (NSAIDs).

Long-term lithium use carries a risk of kidney impairment in some patients, which is why ongoing monitoring matters. The risk is real but manageable with regular blood tests, and most patients on lithium for years do not develop clinically significant kidney problems.

Why Patients Stop Taking It

Medication discontinuation is one of the central challenges in managing bipolar disorder, and lithium is no exception. Side effects, particularly cognitive dulling and weight gain, are commonly cited reasons. Some patients also report missing the energy and reduced need for sleep that characterized their hypomanic or manic states.

The other factor is that lithium works best when taken consistently over time. Missing doses or stopping abruptly can trigger rebound mania, sometimes more severe than what the patient experienced before starting the medication. Discontinuation should always be done gradually and under medical supervision.

What About Alternatives?

Several other medications are used as mood stabilizers in bipolar disorder, including valproate, lamotrigine, and atypical antipsychotics such as quetiapine and olanzapine. Each has its own risk and benefit profile. Research into entirely new mechanisms, including AMPK pathway activators, is also underway for treatment-resistant cases.

Lamotrigine is often preferred for patients whose illness is predominantly depressive. Valproate is effective for acute mania. But for long-term prevention of both poles, and particularly for patients with classic bipolar I, lithium’s evidence base remains the most robust.

The decision about which medication to use is always individual. Factors including episode history, co-occurring conditions, age, kidney health, and pregnancy status all influence the choice. What has not changed is that lithium, after more than seven decades, remains a first-line option that has not been surpassed.

Sources: National Institute of Mental Health | Mayo Clinic | Lancet Psychiatry meta-analysis via PMC

See recent or related posts:

Mania Insights